It has been shown that MAPK inhibitors promote cytotoxicity by enhancing IFN-γ signaling, MHC-1 expression, tumor-infiltrating lymphocytes and upregulating PD-L1 expression[59]. This evidence concerns the gene CD274 and neoplasm.